Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.3M |
| 2 |
WFT
Weatherford International plc
WFT
|
+$16.5M |
| 3 |
ICL Group
ICL
|
+$11.3M |
| 4 |
Liberty Media Series C
FWONK
|
+$9.18M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$6.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.7M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$23.5M |
| 3 |
ExxonMobil
XOM
|
+$11.1M |
| 4 |
IBM
IBM
|
+$8.88M |
| 5 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.81% |
| 2 | Technology | 13.76% |
| 3 | Energy | 11.48% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Staples | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNL
926
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $3.25M | 0.01% |
67,400
-1,500
| -2% | -$83.1K |
|
|
AWAY
927
DELISTED
HOMEAWAY INC COM
AWAY
| $3.24M | 0.01% |
91,300
-800
| -0.9% | -$26.7K |
|
|
DST
928
DELISTED
DST Systems Inc.
DST
| $3.24M | 0.01% |
77,200
-1,800
| -2% | -$81.7K |
|
929
First Horizon
FHN
$12B
| $3.24M | 0.01% |
263,600
-5,600
| -2% | -$67.3K |
|
|
EQC
930
DELISTED
Equity Commonwealth
EQC
| $3.23M | 0.01% |
125,700
-1,900
| -1% | -$50.6K |
|
931
DexCom
DXCM
$33.8B
| $3.23M | 0.01% |
323,200
+4,000
| +1% | +$40.9K |
|
932
Crane NXT
CXT
$2.95B
| $3.22M | 0.01% |
146,829
-2,015
| -1% | -$48.8K |
|
933
Sprouts Farmers Market
SFM
$7.87B
| $3.22M | 0.01% |
110,800
+16,400
| +17% | +$507K |
|
|
BTU
934
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $3.22M | 0.01% |
17,339
-4,840
| -22% | -$1.1M |
|
935
Myriad Genetics
MYGN
$308M
| $3.21M | 0.01% |
83,200
| – | – |
|
|
CAB
936
DELISTED
Cabela's Inc
CAB
| $3.2M | 0.01% |
54,400
-900
| -2% | -$53.8K |
|
937
Charles River Laboratories
CRL
$13.5B
| $3.2M | 0.01% |
53,500
-300
| -0.6% | -$17.2K |
|
938
Bankunited
BKU
$3.35B
| $3.19M | 0.01% |
104,800
-2,200
| -2% | -$70K |
|
939
Dana Inc
DAN
$3.27B
| $3.19M | 0.01% |
166,600
+4,600
| +3% | +$104K |
|
|
STRZA
940
DELISTED
Starz - Series A
STRZA
| $3.19M | 0.01% |
96,442
-2,000
| -2% | -$59.9K |
|
|
MFA
941
MFA Financial
MFA
$928M
| $3.19M | 0.01% |
102,425
-2,150
| -2% | -$70.8K |
|
|
SF
942
Stifel
SF
$12.7B
| $3.18M | 0.01% |
152,420
| – | – |
|
943
Guidewire Software
GWRE
$14.7B
| $3.17M | 0.01% |
71,450
-400
| -0.6% | -$16.9K |
|
944
Compass Minerals
CMP
$1.13B
| $3.16M | 0.01% |
37,500
-800
| -2% | -$71.8K |
|
945
First American
FAF
$7.32B
| $3.15M | 0.01% |
116,000
-1,400
| -1% | -$39K |
|
946
Curtiss-Wright
CW
$26.1B
| $3.14M | 0.01% |
47,700
-500
| -1% | -$33.6K |
|
|
AHL
947
DELISTED
ASPEN Insurance Holding Limited
AHL
| $3.14M | 0.01% |
73,500
-1,000
| -1% | -$42.5K |
|
|
FNFG
948
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $3.14M | 0.01% |
377,100
-7,300
| -2% | -$63.2K |
|
|
PDM
949
Piedmont Realty Trust
PDM
$1.17B
| $3.14M | 0.01% |
178,000
-2,800
| -2% | -$53.7K |
|
950
IQVIA
IQV
$40.1B
| $3.13M | 0.01% |
56,100
-900
| -2% | -$50.3K |
|
Similar funds
Swiss National Bank's Q3 2014 Portfolio in Review
As of Q3 2014, Swiss National Bank held 2,547 positions worth $26.1B, down 3.5% from $27B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 1.3%. Swiss National Bank opened 15 new positions and exited 18, leaving the 2,547-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Energy.
- Swiss National Bank's largest Q3 2014 buy was Weatherford International plc: 735,946 shares worth $15.3M.
- Swiss National Bank added most to Allergan plc in Q3 2014, an estimated $18.3M increase.
- Swiss National Bank's biggest Q3 2014 reduction was Apple, cutting an estimated $23.7M.
- Swiss National Bank fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $23.5M.
- Swiss National Bank's ten largest holdings make up 14% of its $26.1B portfolio in Q3 2014.
- Swiss National Bank opened 15 new positions and closed 18 in Q3 2014.
- Swiss National Bank's portfolio value fell 3.5% quarter-over-quarter to $26.1B.
Based on Swiss National Bank's 13F filing for Q3 2014, filed 4 Nov 2014.